Category (ID)
|
Title (or Source)
|
EA
-logP
|
MA
-logP
|
EA Gene Set
|
MA Gene Set
|
Biological Process (GO:0198738)
|
cell-cell signaling by wnt
|
10
|
10
|
CSNK1G2,DDB1,DVL2,PLCB1,
SDC1,SOSTDC1,TLE3
|
CDH2,CPE,FERMT2,FUZ,PORCN,PPP2R1A,
PRICKLE2,PSMD3,PTPRU,TNRC6B
|
Biological Process (GO:0016055)
|
Wnt signaling pathway
|
10
|
10
|
CSNK1G2,DDB1,DVL2,PLCB1,
SDC1,SOSTDC1,TLE3
|
CDH2,CPE,FERMT2,FUZ,PORCN,PPP2R1A,
PRICKLE2,PSMD3,PTPRU,TNRC6B
|
Pathway (1269594) |
Signaling by Wnt |
4.75 |
4.00 |
CSNK1G2,DVL2,PLCB1,TLE3 |
PORCN,PPP2R1A,PSMD3,TNRC6B |
Biological Process (GO:0060070)
|
canonical Wnt signaling pathway
|
10
|
10
|
CSNK1G2,DVL2,SDC1,
SOSTDC1,TLE3
|
CDH2,FUZ,PORCN,PSMD3,PTPRU
|
Biological Process (GO:0030111) |
regulation of Wnt signaling pathway |
5.38 |
10 |
CSNK1G2,DVL2,SOSTDC1,TLE3 |
CDH2,FUZ,PPP2R1A,PSMD3,PTPRU |
Biological Process (GO:0060828) |
regulation of canonical Wnt signaling
pathway |
5.80 |
5.04 |
CSNK1G2,DVL2,SOSTDC1,TLE3 |
CDH2,FUZ,PSMD3,PTPRU |
Biological Process (GO:0090090) |
negative regulation of canonical Wnt
signaling pathway |
4.60 |
5.88 |
DVL2,SOSTDC1,TLE3 |
CDH2,FUZ,PSMD3,PTPRU |
Biological Process (GO:0030178) |
negative regulation of Wnt signaling
pathway |
4.36 |
5.56 |
DVL2,SOSTDC1,TLE3 |
CDH2,FUZ,PSMD3,PTPRU |
Pubmed (30389854) |
WNT/β-catenin signaling plays a crucial role in
myoblast fusion through regulation of nephrin expression during
development. |
0 |
5.02 |
|
CDH2,FERMT2 |
Biological Process (GO:0022603) |
regulation of anatomical structure
morphogenesis |
0 |
4.94 |
|
CDH2,CPE,FERMT2,FUZ,PRICKLE2,PSMD3 |
Biological Process (GO:0001736) |
establishment of planar polarity |
0 |
4.50 |
|
FUZ,PRICKLE2,PSMD3 |
Biological Process (GO:0007164) |
establishment of tissue polarity |
0 |
4.49 |
|
FUZ,PRICKLE2,PSMD3 |
Biological Process (GO:0035567) |
non-canonical Wnt signaling pathway |
0 |
4.30 |
|
PRICKLE2,PSMD3,TNRC6B |
Biological Process (GO:0001738) |
morphogenesis of a polarized
epithelium |
0 |
4.30 |
|
FUZ,PRICKLE2,PSMD3 |
Pathway (1269487) |
Signaling by SCF-KIT |
0 |
4.00 |
|
PPP2R1A,PSMD3,PTPRU,TNRC6B |
Pubmed (28619992) |
Patterning and gastrulation defects caused by the
tw18 lethal are due to loss of Ppp2r1a. |
0 |
5.13 |
|
CDH2,PPP2R1A |
Interaction (int:BBS12) |
BBS12 interactions |
0 |
5.24 |
|
FERMT2,PPP2R1A |
Drug (CID000350833) |
purine riboside 5’-monophosphate |
0 |
5.11 |
|
PORCN,PSMD3 |
Drug (CID000001233) |
ibotenic acid |
0 |
4.76 |
|
CPE,PORCN,PSMD3 |
Biological Process (GO:0045445) |
myoblast differentiation |
5.44 |
0 |
PLCB1,SDC1,SOSTDC1 |
|
Pathway (PW:0000154) |
inositol phosphate metabolic |
4.21 |
0 |
CSNK1G2,PLCB1 |
|
Pathway (1269601) |
Disassembly of the destruction complex and
recruitment of AXIN to the membrane |
3.88 |
0 |
CSNK1G2,DVL2 |
|
Pathway (1269599) |
TCF dependent signaling in response to WNT |
3.62 |
0 |
CSNK1G2,DVL2,TLE3 |
|
Pubmed (23153495) |
Sox2 in the dermal papilla niche controls hair
growth by fine-tuning BMP signaling in differentiating hair shaft
progenitors. |
5.46 |
0 |
SDC1,SOSTDC1 |
|
Pubmed (17041588) |
CUL4-DDB1 ubiquitin ligase interacts with multiple
WD40-repeat proteins and regulates histone methylation. |
4.96 |
0 |
DDB1,TLE3 |
|
Pubmed (18351662) |
WNT signaling affects gene expression in the ventral
diencephalon and pituitary gland growth. |
4.62 |
0 |
DVL2,SOSTDC1 |
|
Interaction (int:DCAF16) |
DCAF16 interactions |
4.31 |
0 |
CSNK1G2,DDB1 |
|
Coexpression (M7672) |
Genes down-regulated in the in vitro follicular
dendritic cells from peripheral lymph nodes (96h): Pam2CSK4 versus
tretinoin [PubChem=444795]. |
4.68 |
0 |
CSNK1G2,PLCB1,TLE3 |
|